Drug recall D-0784-2026

Class II Ongoing reported Sep 2, 2026

Product

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Reason for recall

Subpotent Drug

Lots and codes

a) Lot #: D2402642, Exp. Date 11/30/2026 b) Lot #: D2401832, Exp. Date 08/31/2026; D2402525, D2402527, D2402526, D2402644, D2402643, Exp. Date 11/30/2026.

Recall details

Recalling firm
ACCORD HEALTHCARE, INC., Raleigh, NC
Quantity
N/A
Distribution
Nationwide within the United States
Type
Voluntary: Firm initiated
Recall initiated
August 6, 2026

Related products